Related Experiment Video
Updated: Feb 28, 2026
11:14
Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
Published on: November 10, 2013
59.0K
Natural Compounds Derived from Chilean Species and Their Cytotoxic Potential Against Cancer
Tania Koning1, Gloria M Calaf1
1Instituto de Alta Investigación, Universidad de Tarapacá, Arica 1000000, Chile.
Cancers
|February 27, 2026
Summary
Twelve Chilean plant species show potential cytotoxic properties against cancer. Further research into these natural products could lead to new cancer prevention therapies.
Area of Science:
- Phytochemistry
- Pharmacology
- Oncology
Background:
- Cancer is a leading cause of death globally, necessitating novel therapeutic strategies.
- Medicinal plants have historically been used for cancer treatment and remain important in modern medicine.
- Chile's rich biodiversity offers a promising source of natural products with potential anti-cancer activity.
Purpose of the Study:
- To review and consolidate evidence on the cytotoxic properties of twelve Chilean plant species against cancer.
- To highlight the potential of these natural products for cancer prevention and treatment development.
Main Methods:
- Comprehensive literature review of scientific studies.
- Analysis of documented cytotoxic effects of plant extracts and isolated compounds.
- Examination of mechanisms of action, including cell death induction and anti-angiogenesis.
Main Results:
- Twelve Chilean species (e.g., *Leptocarpha rivularis*, *Peumus boldus*) exhibit significant cytotoxic potential against cancer cells.
- These species induce cancer cell death, reduce viability, and inhibit growth through apoptosis and cell cycle arrest.
- Demonstrated anti-angiogenic effects and high specificity suggest targeted anti-cancer activity.
Conclusions:
- Chilean medicinal plants represent a valuable resource for anti-cancer drug discovery.
- Further research is needed to fully characterize bioactive compounds and their mechanisms of action.
- This review provides a foundation for developing novel therapeutic applications from Chilean natural products.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
691
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
691
01:25Mutagenicity and Carcinogenicity
2.1K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
2.1K
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
01:27Cytotoxic T Cells-mediated Immune Response
7.7K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.7K
02:34Inhibition of Cdk Activity
6.1K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K